Article Dans Une Revue Neurology Neuroimmunology & Neuroinflammation Année : 2021

Delayed Benefit From Aggressive Immunotherapy in Waxing and Waning Anti-IgLON5 Disease

Résumé

Anti-IgLON5 disease is a rare disorder characterized by the variable association of movement disorders, sleep disturbances, cognitive impairment, bulbar symptoms, and respiratory dysfunction.1,2 Pathophysiology likely involves both autoimmune and neurodegenerative processes, and prognosis is considered to be poor.3,4 Here, we report a case with a waxing and waning course, who eventually responded well to aggressive and sustained immunotherapy.
Fichier principal
Vignette du fichier
e1009.full.pdf (475) Télécharger le fichier
Origine Publication financée par une institution

Dates et versions

hal-03229605 , version 1 (19-05-2021)

Identifiants

Citer

Pauline Shambrook, Adèle Hesters, Clémence Marois, Daniel Zemba, Jérôme Servan, et al.. Delayed Benefit From Aggressive Immunotherapy in Waxing and Waning Anti-IgLON5 Disease. Neurology Neuroimmunology & Neuroinflammation, 2021, 8 (4), pp.e1009. ⟨10.1212/NXI.0000000000001009⟩. ⟨hal-03229605⟩
45 Consultations
104 Téléchargements

Altmetric

Partager

More